Profil
Ajay Madan served as Vice President-Preclinical Development at Neurocrine Biosciences, Inc. from 2013 to 2016.
Prior to that, he was Chief Scientific Officer at XenoTech LLC in 2001-2002.
Currently, he is Vice President-Development at Crinetics Pharmaceuticals, Inc. since 2016.
Dr. Madan received his undergraduate degree from Birla Institute of Technology & Science and his doctorate from the University of Kansas.
Anciens postes connus de Ajay Madan
| Sociétés | Poste | Fin |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2022 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/07/2016 |
XenoTech LLC
 XenoTech LLC BiotechnologyHealth Technology XenoTech LLC distributes and evaluates pharmaceutical products. The firm offers metabolite production kits, recombinant CYPs, and custom products. It also provides analytical services, enzyme induction and inhibition, and in vitro toxicology. The company was founded by Andrew Parkinson in 1994 and is headquartered in Kansas City, KS. | Corporate Officer/Principal | 01/01/2002 |
Formation de Ajay Madan
| Birla Institute of Technology & Science | Undergraduate Degree |
| University of Kansas | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
XenoTech LLC
XenoTech LLC BiotechnologyHealth Technology XenoTech LLC distributes and evaluates pharmaceutical products. The firm offers metabolite production kits, recombinant CYPs, and custom products. It also provides analytical services, enzyme induction and inhibition, and in vitro toxicology. The company was founded by Andrew Parkinson in 1994 and is headquartered in Kansas City, KS. | Health Technology |
